Showing 81-90 of 3150 results for "".
Robert Grant Steps Down at Alphaeon; Skin Cancer Special Edition
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-robert-grant-steps-down-at-alphaeon-skin-cancer-special-edition/18595/Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, CA, where he serves as Chairman. Also in this issue, a closer look at skin cancer. May is SCynosure, Cutera Laser Clearances; Surgeon General Takes on Skin Cancer
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cynosure-cutera-laser-clearances-surgeon-general-takes-on-skin-cancer/19096/In this edition of DermWireTV, from the publishers of Practical Dermatology® and Modern Aesthetics® host Devyn Gehrit offers highlights of the annual summer meeting, explores a new skin cancer initiative by the Surgeon General, and covers FDA clearances for Cynosure and Cutera laser systems.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.Is this the Golden Age of Hair Loss Treatment?
https://practicaldermatology.com/topics/hair-nails/is-this-the-golden-age-of-hair-loss-treatment/24036/A perfect storm of many new, unrelated scientific developments also has the potential to fundamentally reshape the way we think about a disease or disease group. Dr. Peter C. Friedman believes many recent breakthroughs have profoundly changed how general dermatologists can manage patients with hairMore than Just Oil Factories: A New Understanding of the Function of Sebaceous Glands
https://practicaldermatology.com/columns/clinical-focus-1/more-than-just-oil-factories-a-new-understanding-of-the-function-of-sebaceous-glands/23686/The sebaceous glands function as both immune and endocrine organs.Getting The Red Out: Expert Tips
https://practicaldermatology.com/topics/practice-management/getting-the-red-out-expert-tips/20701/Dermatologists share their go-to approaches for reducing facial redness in rosacea.Journal Club: Updated Clinical Practice Guidelines
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-updated-clinical-practice-guidelines/32316/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with new Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, about the updated clinical practice guidelines for atopic dermatitis published in the Journal of Dermatology in December.Saeki H, et alDermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-birch-triterpenes-t-gel-gets-fda-approval-for-eb-vte-risk-is-lower-in-patients-with-ad-and-are-topical-steroids-affecting-bone-health/20233/A birch bark extract topical from Chiesi Global Rare Diseases represents the latest in treatment approvals for epidermolysis bullosa. Patients with atopic dermatitis may have a decreased risk for developing venous thromboembolism. Commonly prescribed topical steroids may raise some patients' risk foA Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Global Aesthetics Trends: 5 Take-aways
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/global-aesthetics-trends-5-take-aways/23795/New data on the global aesthetics market show there’s expansion in sheer patient volume as well as in who is seeking cosmetic treatments.